سعر انسوليناجيبت ان 100 وحدة دولية / مل 10 مل فيال 2025

• To improve glycemic control in adults and pediatric patients with diabetes mellitus.Population: Adults and pediatric patientsDailyMed (U.S. National Library of Medicine)

• Hypoglycaemia, allergic reactions, injection-site reactions, lipodystrophy, pruritus, rash, weight gain and oedema; localized cutaneous amyloidosis at injection sites has been reported.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• During episodes of hypoglycaemia.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Hypersensitivity to the insulin or to any of the excipients.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Never share pens, cartridges or syringes between patients, even if the needle is changed.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Changes in insulin regimen (strength, manufacturer, type, injection site or method) may cause hyper- or hypoglycaemia and must be made under close medical supervision with increased glucose monitoring.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Hypoglycaemia is the most common adverse reaction and may be life-threatening; accidental mix-ups between insulin products can occur, so check the label before each injection.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Drugs that may increase hypoglycaemia risk (antidiabetic agents, ACE inhibitors, ARBs, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogues, sulfonamide antibiotics)May increase the risk of hypoglycaemia; dose adjustment and more frequent glucose monitoring may be required.DailyMed (U.S. National Library of Medicine)
• Drugs that may reduce the glucose-lowering effect (e.g. atypical antipsychotics, corticosteroids, danazol, diuretics, oestrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics, thyroid hormones)May decrease the blood-glucose-lowering effect; dose adjustment and more frequent glucose monitoring may be required.DailyMed (U.S. National Library of Medicine)
• Beta-blockers, clonidine, guanethidine, reserpineSigns and symptoms of hypoglycaemia may be reduced or absent; increase glucose monitoring.DailyMed (U.S. National Library of Medicine)

• Published data over decades have not established an association between human insulin use in pregnancy and major birth defects, miscarriage or adverse maternal or fetal outcomes; poorly controlled diabetes in pregnancy carries risks to mother and fetus.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Exogenous human insulin products are transferred into human milk; no adverse reactions in breastfed infants have been reported. Weigh the benefits of breastfeeding against the mother's clinical need for insulin.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.